Interferon DNA polymorphism in chronic leukemia.

doi:10.3109/10428199409051658

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Interferon DNA polymorphism in chronic leukemia.

Leukemia & lymphoma - 1 Mar 1994

Rozenblum E, Larripa I, Barazzutti L, Rendo P, Avalos J S

Abstract excerpt

The interferon (IFN) system (alpha, beta and gamma IFNs) is closely related to the first line of defenses against viral and tumoral diseases. Chronic leukemic and chronic lymphoproliferative patients respond in variable degrees to therapy with exogenous IFN. Remission after treatment with IFN-alp...

Topics

Adult
Aged
Alleles
DNA Probes
Deoxyribonucleases, Type II Site-Specific
Female
Humans
Interferon-alpha
Interferon-beta
Interferon-gamma
Leukemia, Hairy Cell
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Polymorphism, Restriction Fragment Length
Reference Values
Restriction Mapping

Source

Open in PubMed

Identifiers

PMID: 7912973
DOI: 10.3109/10428199409051658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7912973-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics